DE602004003173D1 - Verwendung von konjugierter Linolsäure zur Behandlung der Erkältung - Google Patents

Verwendung von konjugierter Linolsäure zur Behandlung der Erkältung

Info

Publication number
DE602004003173D1
DE602004003173D1 DE602004003173T DE602004003173T DE602004003173D1 DE 602004003173 D1 DE602004003173 D1 DE 602004003173D1 DE 602004003173 T DE602004003173 T DE 602004003173T DE 602004003173 T DE602004003173 T DE 602004003173T DE 602004003173 D1 DE602004003173 D1 DE 602004003173D1
Authority
DE
Germany
Prior art keywords
common cold
treatment
linoleic acid
conjugated linoleic
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004003173T
Other languages
English (en)
Other versions
DE602004003173T2 (de
Inventor
Marianne O'shea
Ulrike Schmid
Ingrid Celestina Maria Mohede
Frederick William Cain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Loders Croklaan BV
Original Assignee
Loders Croklaan BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loders Croklaan BV filed Critical Loders Croklaan BV
Publication of DE602004003173D1 publication Critical patent/DE602004003173D1/de
Application granted granted Critical
Publication of DE602004003173T2 publication Critical patent/DE602004003173T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
DE602004003173T 2003-07-16 2004-04-27 Verwendung von konjugierter Linolsäure zur Behandlung der Erkältung Expired - Lifetime DE602004003173T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US619549 2003-07-16
US10/619,549 US20050014832A1 (en) 2003-07-16 2003-07-16 Treatment

Publications (2)

Publication Number Publication Date
DE602004003173D1 true DE602004003173D1 (de) 2006-12-28
DE602004003173T2 DE602004003173T2 (de) 2007-09-27

Family

ID=33477076

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004003173T Expired - Lifetime DE602004003173T2 (de) 2003-07-16 2004-04-27 Verwendung von konjugierter Linolsäure zur Behandlung der Erkältung

Country Status (11)

Country Link
US (2) US20050014832A1 (de)
EP (1) EP1498119B1 (de)
JP (1) JP2005035975A (de)
KR (2) KR20050010464A (de)
AT (1) ATE345121T1 (de)
AU (1) AU2003257514B2 (de)
CA (1) CA2465681A1 (de)
DE (1) DE602004003173T2 (de)
ES (1) ES2280907T3 (de)
PL (1) PL1498119T3 (de)
PT (1) PT1498119E (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080193550A1 (en) * 2004-05-11 2008-08-14 Fonterra Corporate Research And Development Limited Cla-Enriched Milkfat and Uses Thereof
NZ543486A (en) * 2005-11-10 2009-03-31 Fonterra Corporate Res And Dev Compositions of CIS-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof
JP2008115168A (ja) * 2006-10-12 2008-05-22 Daiichi Sankyo Healthcare Co Ltd 抗アデノウイルス剤
CN103781158A (zh) * 2013-11-30 2014-05-07 北京智谷睿拓技术服务有限公司 无线网络接入方法及接入装置
US11197824B2 (en) * 2020-01-16 2021-12-14 David Changaris Solution and method for reducing the virulence of viruses, bacteria,yeasts, or fungus
CN111743888B (zh) * 2020-06-16 2021-10-22 广州医科大学附属第一医院 (2z,4e)-2,4-癸二烯酸在制备用于治疗流感病毒引起的炎症的药物方面的应用
WO2022029334A1 (en) * 2020-08-07 2022-02-10 Gbiotech S.À.R.L. Combination therapies for treating coronavirus infection

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293358A (en) * 1980-05-07 1981-10-06 The Firestone Tire & Rubber Company Method and apparatus for accurately positioning a bead bundle
US4851437A (en) * 1986-08-12 1989-07-25 Elena Avram Tung oil compositions and use for treatment of body deficiencies
EP0396251A3 (de) * 1989-03-31 1992-07-08 National University Of Singapore Verwendung von Fettsäuren zur Behandlung von mit Cytokinen assoziierten Krankheiten
US5674901A (en) * 1995-06-01 1997-10-07 Wisconsin Alumni Research Foundation Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
US5585400A (en) * 1996-02-27 1996-12-17 Wisconsin Alumni Research Foundation Methods of attenuating the allergic response in animals
US6674901B1 (en) * 1999-04-21 2004-01-06 Hewlett-Packard Development Company, L.P. Document analysis system and method
US6077868A (en) * 1999-07-20 2000-06-20 Wisconsin Alumni Research Foundation Selective inhibition of cyclooxygenase-2
EP1097708B1 (de) * 1999-11-02 2003-09-17 Loders Croklaan B.V. Verwendung von trans-trans-Isomeren von konjugierter Linolsäure
US20030215465A1 (en) * 2002-04-25 2003-11-20 Lc Usa Llc Use of conjugated acid derivatives
JP2004010551A (ja) * 2002-06-07 2004-01-15 Nippon Shokubai Co Ltd ビニルエーテル基含有（メタ）アクリル酸エステル類の製造方法
US6897327B2 (en) * 2003-05-08 2005-05-24 Stepan Company Manufacture of conjugated linoleic salts and acids

Also Published As

Publication number Publication date
KR100858988B1 (ko) 2008-09-17
KR20080005335A (ko) 2008-01-11
JP2005035975A (ja) 2005-02-10
DE602004003173T2 (de) 2007-09-27
EP1498119A1 (de) 2005-01-19
AU2003257514B2 (en) 2006-10-19
US20050014832A1 (en) 2005-01-20
AU2003257514A1 (en) 2005-02-03
ES2280907T3 (es) 2007-09-16
PT1498119E (pt) 2007-01-31
ATE345121T1 (de) 2006-12-15
PL1498119T3 (pl) 2007-01-31
KR20050010464A (ko) 2005-01-27
CA2465681A1 (en) 2005-01-16
EP1498119B1 (de) 2006-11-15
US20050038118A1 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
ATE411399T1 (de) Behandlung der huntington's krankheit mit epa
CY1123084T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι
DK1390049T3 (da) Sammensætninger til behandling af dyresygdomme og -syndromer omfattende transferfaktor
EA200802054A1 (ru) Ингибиторы фермента
DE69936102D1 (de) Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
UY27438A1 (es) Composición farmaceútica que comprende un conjugado oligómero-farmaco insulina, método para tratar deficiencia de insulina en un sujeto, método para proveer una composición farmacéutica.
ATE432072T1 (de) Verwendung von adapalen zur behandlung dermatologischer erkrankungen
ATE462427T1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
ATE390142T1 (de) Synergistische zusammensetzung zur behandlung von diabetes mellitus
DE60231804D1 (de) Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomöostase störungen
CY1109551T1 (el) Πρωτεασωμικοι αναστολεις και μεθοδοι χρησιμοποιησης αυτων
HK1070575A1 (en) Use of botulinum toxin for treating cardiovasculardiseases
DE60031710D1 (de) Fettsäurederivat zur behandlung von externen sekretionsstörungen
BR9809115A (pt) Métodos para tratar inflamação e doenças inflamatórias usando inibidores de padprt
ATE511835T1 (de) Biophosphonate zur behandlung von endometriose
EA200700044A1 (ru) Композиция для местного применения
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
DE602004023762D1 (de) Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3-thiosubstituierte indol-2-alkinsäuren
DE602004003173D1 (de) Verwendung von konjugierter Linolsäure zur Behandlung der Erkältung
DE60333205D1 (de) Histaminika zur behandlung von allergischer rhinitis
DE60230155D1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
SE0301883D0 (sv) New use II
NO20045089L (no) Substituerte aminoalkanfosfonsyrer for behandling av neuropatisk smerte, affektive og oppmerksomhetsforstyrrelser, schizofreni, tinnitus, myopi og andre okulaere lidelser

Legal Events

Date Code Title Description
8364 No opposition during term of opposition